Live
Home·Deals·Biotechnology·Gyre Therapeutics acquires Cullgen
SEO URLwww.firestrike.ai/deals/cullgen-gyre-therapeutics-acquisition-2026-1
acquisitionAnnounced · Mar 2, 2026BiotechnologySource · CredibleArticle · Factual
Cullgen
Gyre Therapeutics
Cullgen · Gyre Therapeutics

Gyre Therapeutics acquires Cullgen

David Najork
David Najork · Founding Software Engineer
Published · Updated · 1 min read
ShareXLinkedInEmail
Deal value
Target
Cullgen
Cullgen
San Diego, California
Acquirer
Gyre Therapeutics
Gyre Therapeutics
Full Acquisition
Status
Announced

Gyre Therapeutics agreed to acquire Cullgen. Reported deal value: Undisclosed. Status: Announced. Sector: Biotechnology. Target headquarters context: San Diego, California, United States.

This page summarizes publicly available information about the transaction as of 2026-03-02. Figures and status may change as filings and press coverage update.

Gyre Therapeutics enters into agreement to acquire Cullgen to gain targeted protein degradation platform and pipeline Gyre Therapeutics Inc: Gyre Therapeutics enters into agreement to acquire Cullgen to gain Targeted Protein Degradation Platform and pipeline Gyre Therapeutics Inc: all-stock transaction valued

Deal timeline

Announced
Mar 2, 2026 · marketscreener.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context

This transaction is classified in Biotechnology. Figures and status may change as sources update.

Sources: marketscreener.com · Primary article · FireStrike proprietary index